| Ytd | 11.68% | |
| 1y | 8.03% |
| Open | 119.80 | Prev Close | 119.74 | Low | 117.57 | High | 121.78 | Mkt Cap | 6.83B |
| Vol | 100.01K | Avg Vol | 898.84K | EPS | 2.53 | P/E | 47.76 | Forward P/E | 30.97 |
| Beta | 0.90 | Short Ratio | 3.38 | Inst. Own | 105.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 109.70 | 200-d Avg | 114.85 | 1yr Est | 144.43 |
U.S. stocks rose, Nasdaq Composite up 1%. Natera Inc (NTRA) shares jump 20.5% after strong Q2 result
Construction Partners, Inc. (ROAD) Q3 2026 Earnings Call Transcript
Construction Partners NASDAQ: ROAD reported third-quarter fiscal 2026 revenue growth of 28.2% and ra
Construction Partners (ROAD) came out with quarterly earnings of $1.08 per share, beating the Zacks
Revenue Up 28% Compared to Q3 FY25 Adjusted Net Income Up 34% Compared to Q3 FY25 Adjusted EBITDA Up
Two-decade track record of building the freight forwarding industry's premier agent network now exte
RZR Pro R Boost Delivers Industry-leading 275 Horsepower, Polaris XPEDITION Debuts NUMATIX with Pneu
Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are
Construction Partners, Inc. (NASDAQ: ROAD) stock is surging on Friday after S&P Dow Jones Indice
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260716-1484354/1484354_nsa46.p
Cramer likes APLD, but advises starting small due to losses. He also recommends buying BE as a non-c
Raymond James analyst Patrick Tyler Brown maintains Construction Partners (NASDAQ:ROAD) with a St
Gainers Clovis Oncology, Inc. (NASDAQ: CLVS) shares climbed 47.7% to close at $7.86 on Friday af
Gainers Clovis Oncology, Inc. (NASDAQ: CLVS) shares jumped 44.8% to $7.70 after the company anno
Gainers